查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1701265

學名藥契約製造市場規模、佔有率、趨勢分析報告：按藥品類型、產品類型、給藥途徑、應用、地區和細分市場進行預測，2025 年至 2030 年

Generic Pharmaceuticals Contract Manufacturing Market Size, Share & Trends Analysis Report By Drug Type (Branded, Unbranded), By Product (API, Drug Product), By Route Of Administration, By Application, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

學名藥契約製造市場的成長和趨勢

根據Grand View Research, Inc.的最新報告，預計到2030年全球學名藥契約製造市場規模將達到909.5億美元，2025年至2030年期間的複合年成長率為9.98%。

採用外包帶來的成本和縮短時間的好處正在推動這一行業的發展。世界上有許多人患有慢性疾病。例如，根據美國疾病管制與預防中心的數據，美國每 10 個成年人中就有 6 個患有至少一種慢性病，每 10 個成年人中就有 4 個患有兩種或兩種以上的慢性病。慢性疾病需要長期治療。醫療成本的不斷上漲導致對用於治療慢性病的經濟型學名藥的需求不斷成長。

預計這將支持疫情後該行業的成長。學名藥的監管核准已有所改善。例如，2021年，FDA核准了93種學名藥，而2022年10月，該監管機構核准了95種以上的學名藥。這些改進預計將對學名藥製造產生積極影響並支持該行業的發展。日本政府正不斷努力完善國內學名藥市場。政府也採取措施改善國內學名藥的供應，並鼓勵醫療機構推廣使用學名藥。

因此，預計未來幾年學名藥CMO 活動將會改善。全球藥品支出也在增加。根據IQVIA 2021年4月發布的報告資料，預計未來四到五年全球藥品支出將會增加。報告顯示，2020年全球醫藥支出將達1.265兆美元，2025年將達到1.58兆至1.61兆美元。此外，由於學名藥具有成本效益，預計學名藥的需求將會增加，從而支持該行業的成長。

學名藥契約製造市場報告重點

  • 根據藥品類型，市場分為品牌非專利和非品牌非專利。 2024 年，品牌非專利藥將佔據市場主導地位，銷售額佔 59.40%。
  • 根據產品，市場分為 API 和藥品。 2024 年，API市場佔有率佔有率。
  • 根據給藥途徑，市場分為口服、腸外、局部和其他。 2024 年，口服藥物領域佔據市場主導地位，收入佔有率為 63.73%。
  • 根據應用，這些包括癌症、免疫學、抗糖尿病、神經病學、抗凝血、循環系統、呼吸系統、疼痛、HIV抗病毒等。
  • 預計到 2024 年北美將佔據最大的市場佔有率，達到 38.90%。這是由於美國和加拿大製藥業的成長。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章學名藥契約製造市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/支持市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 技術進步
  • 臨床試驗總數（2024）
    • 各地區臨床試驗總數
    • 臨床試驗總量（按階段）
    • 臨床試驗總量（依應用）
  • 定價模式分析
  • 市場分析工具
    • 波特五大分析
    • PESTEL 與 SWOT 分析
    • COVID-19影響分析

第4章學名藥契約製造市場：按藥品類型進行的估計和趨勢分析

  • 學名藥契約製造市場（按藥品類型）：細分儀表板
  • 學名藥契約製造市場（按藥品類型）：波動分析
  • 藥物類型，2018-2030
  • 品牌非專利
  • 非品牌非專利

第5章學名藥契約製造市場：按產品進行的估計和趨勢分析

  • 學名藥契約製造市場（按產品：細分儀表板）
  • 學名藥契約製造市場（產品方面：波動分析）
  • 按產品，2018-2030
  • API
  • 製藥

第6章學名藥契約製造市場：按給藥途徑的估計和趨勢分析

  • 學名藥契約製造市場（按給藥途徑）：細分儀表板
  • 學名藥契約製造市場（依給藥途徑）：差異分析
  • 依給藥途徑，2018-2030 年
  • 口服
  • 腸外
  • 局部的
  • 其他

第7章學名藥契約製造市場：應用、估計和趨勢分析

  • 學名藥契約製造市場（按應用）：細分儀表板
  • 學名藥契約製造市場（按應用）：波動分析
  • 按應用，2018-2030 年
  • 腫瘤學
  • 免疫學
  • 抗糖尿病藥物
  • 神經病學
  • 抗凝血劑
  • 心血管系統
  • 呼吸系統
  • 疼痛
  • HIV抗病毒藥物
  • 其他

第8章學名藥契約製造市場：按地區估計和趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 泰國
    • 韓國
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章競爭格局

  • 市場參與企業分類
  • 2024年公司市場佔有率分析
  • 公司簡介
    • The Lubrizol Corporation
    • Jubilant Generics Ltd.
    • Recipharm AB
    • Siegfried Holding AG
    • Aurobindo Pharma
    • Cambrex Corp.
    • Alcami Corp., Inc.
    • Catalent, Inc.
    • Acme Generics Pvt Ltd.
    • Syngene International Ltd.
    • Pfizer CentreOne
    • Curia Global, Inc.
    • Metric Contract Services
Product Code: GVR-4-68039-997-7

Generic Pharmaceuticals Contract Manufacturing Market Growth & Trends:

The global generic pharmaceuticals contract manufacturing market size is expected to reach USD 90.95 billion by 2030, registering a CAGR of 9.98% from 2025 to 2030, according to a new report by Grand View Research, Inc. Cost-saving and time-saving benefits associated with the implementation of outsourcing is responsible for driving the industry. A significant number of people globally suffer from chronic diseases. For instance, the CDC states that 6 in 10 adults in the U.S. suffer from at least one chronic disease and 4 in 10 adults suffer from two or more chronic diseases. Chronic diseases are required to be treated for a long time. The high cost of medicines is increasing the demand for cost-effective generic drugs for the treatment of chronic diseases.

This is expected to support the industry's growth post-pandemic. There is an improvement in the regulatory approval of generic drugs. For instance, in 2021, the FDA approved 93 generic drugs, and by October 2022, the regulatory authority approved over 95 generic drugs. Such improvements are expected to have a positive impact on the manufacturing of generic drugs and; thus, support the industry growth. The Japanese government is constantly trying to improve the generic pharmaceuticals market in the country. The government is also taking measures to improve the supply of generics in the country and is also encouraging medical institutes to promote the use of generic drugs.

This is expected to improve CMO activities for generics in the coming years. Global spending on medicines is also on the rise. According to the data provided in a report published by IQVIA in April 2021, global spending on medicine is expected to increase in the next 4-5 years. The report states that global spending on medicine accounted for USD 1, 265 billion in 2020 and is going to reach USD 1,580-1,610 billion by 2025. This is also expected to improve the demand for generic drugs owing to their cost efficiency, thereby supporting the industry in growth.

Generic Pharmaceuticals Contract Manufacturing Market Report Highlights:

  • On the basis of drug type segment, the market is segmented into branded generics, and unbranded generics. In 2024, the branded generics segment dominated the market, accounting for a revenue share of 59.40%.
  • On the basis of the product segment, the market is segmented to API, and Drug Product. API segment accounted for the largest market share in 2024.
  • On the basis of route of administration segment, the market includes oral, parenteral, topical, and others. In 2024, the oral segment dominated the market, accounting for a revenue share of 63.73%.
  • On the basis of application segment, the market includes oncology, immunology, antidiabetic, neurology, anticoagulants, cardiovascular, respiratory, pain, HIV antivirals, and others.
  • North America accounted for the largest market share of 38.90% in 2024. This can be attributed to the growth of the pharmaceutical industries in the U.S. and Canada.

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Parent Market Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Generic Pharmaceuticals Contract Manufacturing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Technological Advancements
  • 3.4. Total volume of clinical trials (2024)
    • 3.4.1. Total volume of clinical trials, by region
    • 3.4.2. Total volume of clinical trials, by phase
    • 3.4.3. Total volume of clinical trials, by application
  • 3.5. Pricing Model Analysis
  • 3.6. Market Analysis Tools
    • 3.6.1. Porter's Five Analysis
    • 3.6.2. PESTEL by SWOT Analysis
    • 3.6.3. COVID-19 Impact Analysis

Chapter 4. Generic Pharmaceuticals Contract Manufacturing Market: Drug Type Estimates & Trend Analysis

  • 4.1. Generic Pharmaceuticals Contract Manufacturing Market, By Drug Type: Segment Dashboard
  • 4.2. Generic Pharmaceuticals Contract Manufacturing Market, By Drug Type: Movement Analysis
  • 4.3. Generic Pharmaceuticals Contract Manufacturing Market Estimates & Forecasts, By Drug Type, 2018 - 2030
  • 4.4. Branded Generics
    • 4.4.1. Branded Generics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Unbranded Generics
    • 4.5.1. Unbranded Generics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Generic Pharmaceuticals Contract Manufacturing Market: Product Estimates & Trend Analysis

  • 5.1. Generic Pharmaceuticals Contract Manufacturing Market, By Product: Segment Dashboard
  • 5.2. Generic Pharmaceuticals Contract Manufacturing Market, By Product: Movement Analysis
  • 5.3. Generic Pharmaceuticals Contract Manufacturing Market Estimates & Forecasts, By Product, 2018 - 2030
  • 5.4. API
    • 5.4.1. API Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Drug Product
    • 5.5.1. Drug Product Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Generic Pharmaceuticals Contract Manufacturing Market: Route of Administration Estimates & Trend Analysis

  • 6.1. Generic Pharmaceuticals Contract Manufacturing Market, By Route of Administration: Segment Dashboard
  • 6.2. Generic Pharmaceuticals Contract Manufacturing Market, By Route of Administration: Movement Analysis
  • 6.3. Generic Pharmaceuticals Contract Manufacturing Market Estimates & Forecasts, By Route of Administration, 2018 - 2030
  • 6.4. Oral
    • 6.4.1. Oral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Parenteral
    • 6.5.1. Parenteral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Topical
    • 6.6.1. Topical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Generic Pharmaceuticals Contract Manufacturing Market: Application Estimates & Trend Analysis

  • 7.1. Generic Pharmaceuticals Contract Manufacturing Market, By Application: Segment Dashboard
  • 7.2. Generic Pharmaceuticals Contract Manufacturing Market, By Application: Movement Analysis
  • 7.3. Generic Pharmaceuticals Contract Manufacturing Market Estimates & Forecasts, By Application, 2018 - 2030
  • 7.4. Oncology
    • 7.4.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Immunology
    • 7.5.1. Immunology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Antidiabetic
    • 7.6.1. Antidiabetic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Neurology
    • 7.7.1. Neurology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Anticoagulants
    • 7.8.1. Anticoagulants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9. Cardiovascular
    • 7.9.1. Cardiovascular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.10. Respiratory
    • 7.10.1. Respiratory Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.11. Pain
    • 7.11.1. Pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.12. HIV Antivirals
    • 7.12.1. HIV Antivirals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.13. Others
    • 7.13.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Generic Pharmaceuticals Contract Manufacturing Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. North America
    • 8.4.1. North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. U.S
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Denmark
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.8. Sweden
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Competitive Scenario
      • 8.5.8.3. Regulatory Framework
      • 8.5.8.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.9. Norway
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Competitive Scenario
      • 8.5.9.3. Regulatory Framework
      • 8.5.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. Thailand
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Competitive Scenario
      • 8.6.6.3. Regulatory Framework
      • 8.6.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.7. Australia
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Competitive Scenario
      • 8.6.7.3. Regulatory Framework
      • 8.6.7.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8. MEA
    • 8.8.1. MEA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Competitive Scenario
      • 8.8.2.3. Regulatory Framework
      • 8.8.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Competitive Scenario
      • 8.8.3.3. Regulatory Framework
      • 8.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Competitive Scenario
      • 8.8.4.3. Regulatory Framework
      • 8.8.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Competitive Scenario
      • 8.8.5.3. Regulatory Framework
      • 8.8.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Company Market Share Analysis, 2024
  • 9.3. Company Profiles
    • 9.3.1. The Lubrizol Corporation
      • 9.3.1.1. Company Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Service Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Jubilant Generics Ltd.
      • 9.3.2.1. Company Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Service Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Recipharm AB
      • 9.3.3.1. Company Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Service Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Siegfried Holding AG
      • 9.3.4.1. Company Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Service Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Aurobindo Pharma
      • 9.3.5.1. Company Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Service Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Cambrex Corp.
      • 9.3.6.1. Company Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Service Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Alcami Corp., Inc.
      • 9.3.7.1. Company Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Service Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Catalent, Inc.
      • 9.3.8.1. Company Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Service Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. Acme Generics Pvt Ltd.
      • 9.3.9.1. Company Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Service Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. Syngene International Ltd.
      • 9.3.10.1. Company Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Service Benchmarking
      • 9.3.10.4. Strategic Initiatives
    • 9.3.11. Pfizer CentreOne
      • 9.3.11.1. Company Overview
      • 9.3.11.2. Financial Performance
      • 9.3.11.3. Service Benchmarking
      • 9.3.11.4. Strategic Initiatives
    • 9.3.12. Curia Global, Inc.
      • 9.3.12.1. Company Overview
      • 9.3.12.2. Financial Performance
      • 9.3.12.3. Service Benchmarking
      • 9.3.12.4. Strategic Initiatives
    • 9.3.13. Metric Contract Services
      • 9.3.13.1. Company Overview
      • 9.3.13.2. Financial Performance
      • 9.3.13.3. Service Benchmarking
      • 9.3.13.4. Strategic Initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Generic Pharmaceuticals Contract Manufacturing Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 4. Global Generic Pharmaceuticals Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 5. Global Generic Pharmaceuticals Contract Manufacturing Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 6. Global Generic Pharmaceuticals Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table 7. Global Generic Pharmaceuticals Contract Manufacturing Market, by Region, 2018 - 2030 (USD Million)
  • Table 8. North America Generic Pharmaceuticals Contract Manufacturing Market, by Country, 2018 - 2030 (USD Million)
  • Table 9. North America Generic Pharmaceuticals Contract Manufacturing Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 10. North America Generic Pharmaceuticals Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 11. North America Generic Pharmaceuticals Contract Manufacturing Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 12. North America Generic Pharmaceuticals Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table 13. U.S. Generic Pharmaceuticals Contract Manufacturing Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 14. U.S. Generic Pharmaceuticals Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 15. U.S. Generic Pharmaceuticals Contract Manufacturing Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 16. U.S. Generic Pharmaceuticals Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table 17. Canada Generic Pharmaceuticals Contract Manufacturing Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 18. Canada Generic Pharmaceuticals Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 19. Canada Generic Pharmaceuticals Contract Manufacturing Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 20. Canada Generic Pharmaceuticals Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table 21. Mexico Generic Pharmaceuticals Contract Manufacturing Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 22. Mexico Generic Pharmaceuticals Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 23. Mexico Generic Pharmaceuticals Contract Manufacturing Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 24. Mexico Generic Pharmaceuticals Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table 25. Europe Generic Pharmaceuticals Contract Manufacturing Market, by Country, 2018 - 2030 (USD Million)
  • Table 26. Europe Generic Pharmaceuticals Contract Manufacturing Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 27. Europe Generic Pharmaceuticals Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 28. Europe Generic Pharmaceuticals Contract Manufacturing Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 29. Europe Generic Pharmaceuticals Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table 30. UK Generic Pharmaceuticals Contract Manufacturing Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 31. UK Generic Pharmaceuticals Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 32. UK Generic Pharmaceuticals Contract Manufacturing Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 33. UK Generic Pharmaceuticals Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table 34. Germany Generic Pharmaceuticals Contract Manufacturing Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 35. Germany Generic Pharmaceuticals Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 36. Germany Generic Pharmaceuticals Contract Manufacturing Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 37. Germany Generic Pharmaceuticals Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table 38. France Generic Pharmaceuticals Contract Manufacturing Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 39. France Generic Pharmaceuticals Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 40. France Generic Pharmaceuticals Contract Manufacturing Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 41. France Generic Pharmaceuticals Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table 42. Italy Generic Pharmaceuticals Contract Manufacturing Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 43. Italy Generic Pharmaceuticals Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 44. Italy Generic Pharmaceuticals Contract Manufacturing Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 45. Italy Generic Pharmaceuticals Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table 46. Spain Generic Pharmaceuticals Contract Manufacturing Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 47. Spain Generic Pharmaceuticals Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 48. Spain Generic Pharmaceuticals Contract Manufacturing Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 49. Spain Generic Pharmaceuticals Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table 50. Denmark Generic Pharmaceuticals Contract Manufacturing Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 51. Denmark Generic Pharmaceuticals Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 52. Denmark Generic Pharmaceuticals Contract Manufacturing Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 53. Denmark Generic Pharmaceuticals Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table 54. Sweden Generic Pharmaceuticals Contract Manufacturing Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 55. Sweden Generic Pharmaceuticals Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 56. Sweden Generic Pharmaceuticals Contract Manufacturing Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 57. Sweden Generic Pharmaceuticals Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table 58. Norway Generic Pharmaceuticals Contract Manufacturing Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 59. Norway Generic Pharmaceuticals Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 60. Norway Generic Pharmaceuticals Contract Manufacturing Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 61. Norway Generic Pharmaceuticals Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table 62. Asia Pacific Generic Pharmaceuticals Contract Manufacturing Market, by Country, 2018 - 2030 (USD Million)
  • Table 63. Asia Pacific Generic Pharmaceuticals Contract Manufacturing Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 64. Asia Pacific Generic Pharmaceuticals Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 65. Asia Pacific Generic Pharmaceuticals Contract Manufacturing Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 66. Asia Pacific Generic Pharmaceuticals Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table 67. Japan Generic Pharmaceuticals Contract Manufacturing Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 68. Japan Generic Pharmaceuticals Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 69. Japan Generic Pharmaceuticals Contract Manufacturing Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 70. Japan Generic Pharmaceuticals Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table 71. China Generic Pharmaceuticals Contract Manufacturing Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 72. China Generic Pharmaceuticals Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 73. China Generic Pharmaceuticals Contract Manufacturing Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 74. China Generic Pharmaceuticals Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table 75. India Generic Pharmaceuticals Contract Manufacturing Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 76. India Generic Pharmaceuticals Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 77. India Generic Pharmaceuticals Contract Manufacturing Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 78. India Generic Pharmaceuticals Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table 79. Thailand Generic Pharmaceuticals Contract Manufacturing Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 80. Thailand Generic Pharmaceuticals Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 81. Thailand Generic Pharmaceuticals Contract Manufacturing Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 82. Thailand Generic Pharmaceuticals Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table 83. South Korea Generic Pharmaceuticals Contract Manufacturing Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 84. South Korea Generic Pharmaceuticals Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 85. South Korea Generic Pharmaceuticals Contract Manufacturing Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 86. South Korea Generic Pharmaceuticals Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table 87. Australia Generic Pharmaceuticals Contract Manufacturing Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 88. Australia Generic Pharmaceuticals Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 89. Australia Generic Pharmaceuticals Contract Manufacturing Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 90. Australia Generic Pharmaceuticals Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table 91. Latin America Generic Pharmaceuticals Contract Manufacturing Market, by Country, 2018 - 2030 (USD Million)
  • Table 92. Latin America Generic Pharmaceuticals Contract Manufacturing Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 93. Latin America Generic Pharmaceuticals Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 94. Latin America Generic Pharmaceuticals Contract Manufacturing Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 95. Latin America Generic Pharmaceuticals Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table 96. Brazil Generic Pharmaceuticals Contract Manufacturing Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 97. Brazil Generic Pharmaceuticals Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 98. Brazil Generic Pharmaceuticals Contract Manufacturing Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 99. Brazil Generic Pharmaceuticals Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table 100. Argentina Generic Pharmaceuticals Contract Manufacturing Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 101. Argentina Generic Pharmaceuticals Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 102. Argentina Generic Pharmaceuticals Contract Manufacturing Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 103. Argentina Generic Pharmaceuticals Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table 104. Middle East & Africa Generic Pharmaceuticals Contract Manufacturing Market, by Country, 2018 - 2030 (USD Million)
  • Table 105. Middle East & Africa Generic Pharmaceuticals Contract Manufacturing Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 106. Middle East & Africa Generic Pharmaceuticals Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 107. Middle East & Africa Generic Pharmaceuticals Contract Manufacturing Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 108. Middle East & Africa Generic Pharmaceuticals Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table 109. South Africa Generic Pharmaceuticals Contract Manufacturing Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 110. South Africa Generic Pharmaceuticals Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 111. South Africa Generic Pharmaceuticals Contract Manufacturing Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 112. South Africa Generic Pharmaceuticals Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table 113. Saudi Arabia Generic Pharmaceuticals Contract Manufacturing Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 114. Saudi Arabia Generic Pharmaceuticals Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 115. Saudi Arabia Generic Pharmaceuticals Contract Manufacturing Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 116. Saudi Arabia Generic Pharmaceuticals Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table 117. UAE Generic Pharmaceuticals Contract Manufacturing Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 118. UAE Generic Pharmaceuticals Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 119. UAE Generic Pharmaceuticals Contract Manufacturing Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 120. UAE Generic Pharmaceuticals Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table 121. Kuwait Generic Pharmaceuticals Contract Manufacturing Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 122. Kuwait Generic Pharmaceuticals Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 123. Kuwait Generic Pharmaceuticals Contract Manufacturing Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 124. Kuwait Generic Pharmaceuticals Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model sizing & forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market snapshot
  • Fig. 11 Segment snapshot 1
  • Fig. 12 Segment snapshot 2
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook, 2024 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2024 (USD Billion)
  • Fig. 16 Generic Pharmaceuticals Contract Manufacturing Market dynamics
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Generic Pharmaceuticals Contract Manufacturing Market: Drug Type outlook and key takeaways
  • Fig. 20 Generic Pharmaceuticals Contract Manufacturing Market: Drug Type movement analysis
  • Fig. 21 Branded Generics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Unbranded Generics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Generic Pharmaceuticals Contract Manufacturing Market: Product outlook and key takeaways
  • Fig. 24 Generic Pharmaceuticals Contract Manufacturing Market: Product movement analysis
  • Fig. 25 API market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Drug Product market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Generic Pharmaceuticals Contract Manufacturing Market: Route of Administration outlook and key takeaways
  • Fig. 28 Generic Pharmaceuticals Contract Manufacturing Market: Route of Administration movement analysis
  • Fig. 29 Oral market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Parenteral market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Topical market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Generic Pharmaceuticals Contract Manufacturing Market: Application outlook and key takeaways
  • Fig. 34 Generic Pharmaceuticals Contract Manufacturing Market: Application movement analysis
  • Fig. 35 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Immunology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Antidiabetic market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Neurology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Anticoagulants market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Cardiovascular market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Respiratory market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Pain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 HIV Antivirals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Regional Marketplace: Key Takeaways
  • Fig. 46 North America Generic Pharmaceuticals Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 U.S. Generic Pharmaceuticals Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Canada Generic Pharmaceuticals Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Mexico Generic Pharmaceuticals Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Europe Generic Pharmaceuticals Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 UK Generic Pharmaceuticals Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 Germany Generic Pharmaceuticals Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 France Generic Pharmaceuticals Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Italy Generic Pharmaceuticals Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Spain Generic Pharmaceuticals Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Denmark outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Sweden outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Norway outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Asia Pacific Generic Pharmaceuticals Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Japan Generic Pharmaceuticals Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 China Generic Pharmaceuticals Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 India Generic Pharmaceuticals Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 Thailand Generic Pharmaceuticals Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 South Korea Generic Pharmaceuticals Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Australia Generic Pharmaceuticals Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Latin America Generic Pharmaceuticals Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Brazil Generic Pharmaceuticals Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 Argentina Generic Pharmaceuticals Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 MEA Generic Pharmaceuticals Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 South Africa Generic Pharmaceuticals Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Fig. Key country dynamics
  • Fig. 92 Saudi Arabia Generic Pharmaceuticals Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 UAE Generic Pharmaceuticals Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 Kuwait Generic Pharmaceuticals Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Key company categorization
  • Fig. 98 Service heat map analysis
  • Fig. 99 Strategic framework